Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2013 Aug 17;12(7):1059–1068. doi: 10.1016/j.cgh.2013.08.015

Table 2.

NCCN Criteria for Further Risk Evaluation for High Risk Syndromes Associated with CRC*

  1. Individuals meeting the Revised Bethesda Guidelines

  2. Individuals with a family history which meets Amsterdam Criteria

  3. Individuals with >10 colorectal adenomas

  4. Individuals with multiple GI hamartomatous polyps or serrated polyposis syndrome

  5. Individuals from a family with a known hereditary syndrome associated with CRC with or without a known mutation

  6. Individuals with a desmoid tumor

*

NCCN Clinical Practice Guidelines in Oncology Version 1.2013, nccn.org